Back to Markets
EXExelixis Inc

Exelixis Inc

EXELNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$50.48

-0.970000 (-1.89%)

As of 05/29/26 EDT · USD

Compare
Low: $33.76Current: $50.48High: $52.96

Key Statistics

Open

$51.41

Day High

$51.72

Day Low

$50.42

Prev. Close

$51.45

VolumeShares traded today.

2.67M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$12.69B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

16.77

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$52.96

52W LowLowest price over the past 52 weeks.

$33.76

50D MAAverage closing price over the last 50 trading days.

$45.89

200D MAAverage closing price over the last 200 trading days.

$42.51

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+1.7%

1M

+13.0%

6M

+17.0%

YTD

+15.8%

1Y

+17.7%

About

Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.

www.exelixis.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade EXEL

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.